SCM
RCEL icon

Sterling Capital Management’s Avita Medical RCEL Stock Holding History

Sterling Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292 Hold
79
– – ﹤0.01% 3187
2025
Q4 		$273 Buy
79
+49
+163% +$196 ﹤0.01% 3217
2025
Q3 		$153 Sell
30
-31
-51% -$162 ﹤0.01% 3225
2025
Q2 		$323 Buy
61
+35
+135% +$255 ﹤0.01% 3200
2025
Q1 		$212 Hold
26
– – ﹤0.01% 3077
2024
Q4 		$333 Hold
26
– – ﹤0.01% 3074
2024
Q3 		$279 Buy
+26
New +$244 ﹤0.01% 3049

Other funds holding RCEL

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.14B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return